| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Salidroside | Acute Liver Injury | 2 | PM | 37556956 | 📋 | Salidroside ameliorates acetaminophen-induced acute liver injury through the inhibition of endoplasmic reticulum stress-mediated ferroptosis by activating the AMPK/SIRT1 pathway |
| Salidroside | Acute Liver Injury | 1 | PM | 32544869 | 📋 | Salidroside protects mice against CCl4-induced acute liver injury via down-regulating CYP2E1 expression and inhibiting NLRP3 inflammasome activation |
| Salidroside | Acute Pancreatitis | 3 | PM | 36747537 | 📋 | Salidroside ameliorates severe acute pancreatitis-induced cell injury and pyroptosis by inactivating Akt/NF-κB and caspase-3/GSDME pathways |
| Salidroside | Acute Pancreatitis | 1 | PM | 35963157 | 📋 | Salidroside alleviates severe acute pancreatitis-triggered pancreatic injury and inflammation by regulating miR-217-5p/YAF2 axis |
| Salidroside | Acute Pancreatitis | 2 | PM | 35322632 | 📋 | Therapeutic effects of salidroside vs pyrrolidine dithiocarbamate against severe acute pancreatitis in rat |
| Salidroside | Binge Eating | 1 | PM | 20837037 | 📋 | Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating |
| Salidroside | Cholestasis | 1 | PM | 38808258 | 📋 | Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K/AKT/GSK-3β signaling pathway and regulating intestinal flora distribution |
| Salidroside | Colitis | 2 | PM | 37504971 | 📋 | Salidroside alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota |
| Salidroside | Colitis | 1 | PM | 31401159 | 📋 | Salidroside attenuates dextran sulfate sodium-induced colitis in mice via SIRT1/FoxOs signaling pathway |
| Salidroside | Colon Cancer | 1 | PM | 25755753 | 📋 | Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway |
| Salidroside | Colorectal Cancer | 2 | PM | 36465266 | 📋 | Effects of Salidroside Combined with Paclitaxel on Proliferation, Migration, and Epithelial Mesenchyme of Colorectal Cancer Cells |
| Salidroside | Colorectal Cancer | 1 | PM | 33749640 | 📋 | Salidroside induces cell apoptosis and inhibits the invasiveness of HT29 colorectal cells by regulating protein kinase R, NF-κB and STAT3 |
| Salidroside | Colorectal Cancer | 4 | PM | 29246220 | 📋 | Inhibition of autophagy enhances synergistic effects of Salidroside and anti-tumor agents against colorectal cancer |
| Salidroside | Colorectal Cancer | 5 | PM | 29115408 | 📋 | Salidroside could enhance the cytotoxic effect of L‑OHP on colorectal cancer cells |
| Salidroside | Colorectal Cancer | 3 | PM | 27748934 | 📋 | Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway |
| Salidroside | Gastric Cancer | 5 | PM | 38436092 | 📋 | Salidroside inhibited the proliferation of gastric cancer cells through up-regulating tumor suppressor miR-1343-3p and down-regulating MAP3K6/MMP24 signal molecules |
| Salidroside | Gastric Cancer | 1 | PM | 34471002 | 📋 | Salidroside induces apoptosis in human gastric cancer cells via the downregulation of ENO1/PKM2/GLUT1 expression |
| Salidroside | Gastric Cancer | 3 | PM | 31918283 | 📋 | Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway |
| Salidroside | Gastric Cancer | 2 | PM | 31432697 | 📋 | Anti-gastric cancer effect of Salidroside through elevating miR-99a expression |
| Salidroside | Gastric Ulcer | 1 | PM | 26241782 | 📋 | Protective activity of salidroside against ethanol-induced gastric ulcer via the MAPK/NF-κB pathway in vivo and in vitro |
| Salidroside | Hepatic Fibrosis | 3 | PM | 38808258 | 📋 | Salidroside alleviates cholestasis-induced liver fibrosis by inhibiting hepatic stellate cells via activation of the PI3K/AKT/GSK-3β signaling pathway and regulating intestinal flora distribution |
| Salidroside | Hepatic Fibrosis | 2 | PM | 34296587 | 📋 | [Study on mechanism of salidroside against liver fibrosis by regulating CXCL16] |
| Salidroside | Hepatic Fibrosis | 1 | PM | 34054552 | 📋 | Salidroside Inhibits CCl 4-Induced Liver Fibrosis in Mice by Reducing Activation and Migration of HSC Induced by Liver Sinusoidal Endothelial Cell-Derived Exosomal SphK1 |
| Salidroside | Hepatic Ischemia-Reperfusion | 1 | PM | 35978104 | 📋 | Salidroside alleviates hepatic ischemia-reperfusion injury during liver transplant in rat through regulating TLR-4/NF-κB/NLRP3 inflammatory pathway |
| Salidroside | Hepatic Ischemia-Reperfusion | 3 | PM | 28721018 | 📋 | Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice |
| Salidroside | Hepatic Ischemia-Reperfusion | 2 | PM | 28411054 | 📋 | Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transition |
| Salidroside | Hepatic Steatosis | 1 | PM | 35061559 | 📋 | Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats |
| Salidroside | Hepatitis | 1 | PM | 33217691 | 📋 | Inhibition of HMGB1 involved in the protective of salidroside on liver injury in diabetes mice |
| Salidroside | Inflammatory Bowel Disease | 1 | PM | 30944705 | 📋 | Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways |
| Salidroside | Intestinal Ischemia-Reperfusion | 1 | PM | 37530723 | 📋 | Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of salidroside on intestine ischemia reperfusion |
| Salidroside | Intestinal Permeability | 2 | PM | 37732575 | 📋 | [Salidroside improves intestinal mucosal immune status of rats under compound stress of hypoxia and training via inhibiting TLR4/NF-κB signaling pathway] |
| Salidroside | Intestinal Permeability | 1 | PM | 36684648 | 📋 | Salidroside protects against intestinal barrier dysfunction in septic mice by regulating IL‑17 to block the NF‑κB and p38 MAPK signaling pathways |
| Salidroside | Liver Cancer | 3 | PM | 37839277 | 📋 | Crosstalk between autophagy inhibitor and salidroside-induced apoptosis: A novel strategy for autophagy-based treatment of hepatocellular cancer |
| Salidroside | Liver Cancer | 2 | PM | 32439176 | 📋 | Salidroside induces apoptosis and triggers endoplasmic reticulum stress in human hepatocellular carcinoma |
| Salidroside | Liver Cancer | 1 | PM | 30942419 | 📋 | Salidroside suppresses the metastasis of hepatocellular carcinoma cells by inhibiting the activation of the Notch1 signaling pathway |
| Salidroside | Liver Damage | 2 | PM | 38333759 | 📋 | Salidroside alleviates LPS-induced liver injury and inflammation through SIRT1- NF-κB pathway and NLRP3 inflammasome |
| Salidroside | Liver Damage | 1 | PM | 32703432 | 📋 | Salidroside alleviated hypoxia-induced liver injury by inhibiting endoplasmic reticulum stress-mediated apoptosis via IRE1α/JNK pathway |
| Salidroside | MAFLD | 1 | PM | 31920355 | 📋 | Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation |
| Salidroside | Nasopharyngeal Cancer | 1 | PM | 35220889 | 📋 | Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis |
| Salidroside | Non-Alcoholic Steatohepatitis | 1 | PM | 34292604 | 📋 | Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice |
| Salidroside | Non-Alcoholic Steatohepatitis | 4 | PM | 31986416 | 📋 | Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis |
| Salidroside | Non-Alcoholic Steatohepatitis | 3 | PM | 28255329 | 📋 | Salidroside Modulates Insulin Signaling in a Rat Model of Nonalcoholic Steatohepatitis |
| Salidroside | Non-Alcoholic Steatohepatitis | 2 | PM | 27075663 | 📋 | Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats |
| Salidroside | Pancreatic Cancer | 2 | PM | 32758338 | 📋 | Salidroside inhibits proliferation, migration and invasion of human pancreatic cancer PANC1 and SW1990 cells through the AKT and ERK signaling pathway |
| Salidroside | Pancreatic Cancer | 1 | PM | 31162697 | 📋 | Salidroside ameliorated hypoxia-induced tumorigenesis of BxPC-3 cells via downregulating hypoxia-inducible factor (HIF)-1α and LOXL2 |
| Salidroside | Pancreatic Injury | 1 | PM | 35963157 | 📋 | Salidroside alleviates severe acute pancreatitis-triggered pancreatic injury and inflammation by regulating miR-217-5p/YAF2 axis |
| Salidroside | Ulcerative Colitis | 1 | PM | 36331009 | 📋 | Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis-associated Th17/Treg imbalance |
| Salidroside | Ulcerative Colitis | 2 | PM | 31849652 | 📋 | The Abilities of Salidroside on Ameliorating Inflammation, Skewing the Imbalanced Nucleotide Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3/Autophagy, and Maintaining Intestinal Barrier Are Profitable in Colitis |
